We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$291M
AUM Growth
+$36.7M
Cap. Flow
+$21.1M
Cap. Flow %
7.25%
Top 10 Hldgs %
61.7%
Holding
31
New
6
Increased
13
Reduced
4
Closed
2

Top Buys

Rank Stock Value
1
AMWL icon
American Well
AMWL
+$10.5M
2
DXCM icon
DexCom
DXCM
+$7.84M
3
OM icon
Outset Medical
OM
+$4.52M
4
INSP icon
Inspire Medical Systems
INSP
+$3.69M
5
PRVA icon
Privia Health
PRVA
+$3.54M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$9.56M
2
AGIO icon
Agios Pharmaceuticals
AGIO
+$6.66M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.83M
4
IQV icon
IQVIA
IQV
+$3.44M
5
NTRA icon
Natera
NTRA
+$532K

Sector Composition

Rank Sector Weight
1 Healthcare 97.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
1
AstraZeneca
AZN
$251B
$23.9M 8.22%
199,895
+21,500
+12% +$2.36M
HUM icon
2
Humana
HUM
$46.3B
$21.1M 7.25%
47,721
+2,800
+6% +$1.22M
IQV icon
3
IQVIA
IQV
$39.8B
$20.7M 7.09%
85,277
-14,900
-15% -$3.44M
NTRA icon
4
Natera
NTRA
$45.9B
$18.5M 6.36%
163,194
-5,200
-3% -$532K
ALNY icon
5
Alnylam Pharmaceuticals
ALNY
$29B
$18.3M 6.29%
108,179
– –
UTHR icon
6
United Therapeutics
UTHR
$22.7B
$17.6M 6.03%
98,038
+4,938
+5% +$940K
ARGX icon
7
argenx
ARGX
$54.2B
$16M 5.5%
53,232
+10,600
+25% +$3.01M
AXNX
8
DELISTED
Axonics, Inc. Common Stock
AXNX
$14.9M 5.1%
234,565
+39,600
+20% +$2.34M
DXCM icon
9
DexCom
DXCM
$33.1B
$14.6M 5.01%
136,800
+81,600
+148% +$7.84M
VRTX icon
10
Vertex Pharmaceuticals
VRTX
$133B
$14.1M 4.85%
70,144
-18,300
-21% -$3.83M
AGIO icon
11
Agios Pharmaceuticals
AGIO
$1.95B
$13M 4.45%
235,513
-119,137
-34% -$6.66M
BPMC
12
DELISTED
Blueprint Medicines
BPMC
$12.4M 4.25%
140,763
+7,600
+6% +$696K
INSP icon
13
Inspire Medical Systems
INSP
$1.73B
$10.8M 3.72%
56,053
+18,600
+50% +$3.69M
ADPT icon
14
Adaptive Biotechnologies
ADPT
$4.05B
$10.5M 3.61%
257,827
+55,607
+27% +$2.16M
MRTX
15
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$9.35M 3.21%
57,900
+21,500
+59% +$3.45M
OM icon
16
Outset Medical
OM
$91.4M
$9.3M 3.19%
12,400
+5,913
+91% +$4.52M
AMWL icon
17
American Well
AMWL
$231M
$9.15M 3.14%
+36,380
New +$10.5M
DRNA
18
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$6.01M 2.06%
161,125
– –
CANO
19
DELISTED
Cano Health, Inc.
CANO
$6M 2.06%
4,961
– –
CMAX
20
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$4.87M 1.67%
12,593
+1,257
+11% +$499K
PRVA icon
21
Privia Health
PRVA
$2.86B
$4.26M 1.46%
+96,000
New +$3.54M
GH icon
22
Guardant Health
GH
$22.4B
$3.51M 1.2%
28,260
– –
SEER icon
23
Seer Inc
SEER
$119M
$2.74M 0.94%
83,500
– –
KYMR icon
24
Kymera Therapeutics
KYMR
$9.03B
$1.79M 0.62%
+37,000
New +$1.61M
CCCC icon
25
C4 Therapeutics
CCCC
$400M
$1.79M 0.61%
+47,200
New +$1.69M
1
2

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Eagle Health Investments's Q2 2021 Portfolio in Review

As of Q2 2021, Eagle Health Investments held 31 positions worth $291M, up 14% from $255M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Eagle Health Investments deployed $21.1M of net new capital in Q2 2021, opening 6 new positions and adding to 13 existing holdings. Its largest new stake was American Well: 36,380 shares worth $9.15M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 95% a quarter earlier.

On the sell side, the largest reduction was Agios Pharmaceuticals, an estimated $6.66M trimmed.

  • Eagle Health Investments's largest Q2 2021 buy was American Well: 36,380 shares worth $9.15M.
  • Eagle Health Investments added most to DexCom in Q2 2021, an estimated $7.84M increase.
  • Eagle Health Investments's biggest Q2 2021 reduction was Agios Pharmaceuticals, cutting an estimated $6.66M.
  • Eagle Health Investments fully exited Thermo Fisher Scientific in Q2 2021, selling an estimated $9.56M.
  • Eagle Health Investments's ten largest holdings make up 62% of its $291M portfolio in Q2 2021.
  • Eagle Health Investments opened 6 new positions and closed 2 in Q2 2021.
  • Eagle Health Investments's portfolio value rose 14% quarter-over-quarter to $291M.

Based on Eagle Health Investments's 13F filing for Q2 2021, filed 19 Jul 2021.